tsn

COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers

 38
3 comments
Staff at TrialSite | Quality Journalism
Jan. 11, 2025, 5:00 p.m.

This Spanish study, funded by Roche Diagnostics and led by Leire Fernández-Ciriza from Clínica Universidad de Navarra, Pamplona, and colleagues, explores the immune response to COVID-19 booster doses in healthcare workers, focusing on reinfection and primary vaccination schedules. Researchers aimed to determine whether booster doses enhanced antibody responses to the Omicron variant, particularly in those with prior infections.

The recent piece was published in Viruses.

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News